You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Walker Monitor to Inhibit Freezing of Gait by Individuals with Parkinson's Diseas

    SBC: VORTANT TECHNOLOGIES LLC            Topic: NIA

    DESCRIPTION (provided by applicant): Freezing of Gait (FOG) effects the majority of the approximately one million individuals who have Parkinson's disease nationwide and causes a cessation of movement that patients describe as feeling as if their feet are glued to the ground . FOG most often occurs in the mature stages of Parkinson's disease and results in a loss of balance and severe falls. Thes ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Evaluation of NBD Peptides as an Adjunct Therapy for the Treatment of Non-Hodgkin

    SBC: THERALOGICS, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The NF-?B family of transcription factors plays a central role in the regulation of lymphocyte proliferation, differentiation and survival. Aberrant constitutive activation of NF-?B has been identified in many different aggressive lymphoid malignancies in humans and contributes to lymphomagenesis and chemotherapeutic resistance by driving the expression of NF-? ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Phosphate Binder: Effects on Hyperphosphatemia, Vascular Calcification and Bo

    SBC: BIOLINK LIFE SCIENCES INC            Topic: NIDDK

    DESCRIPTION (provided by applicant): In patients with chronic kidney disease (CKD), phosphate retention may contribute to progression of renal failure and is a major factor in the development of secondary hyperparathyroidism and vascular calcification. Progression of injury is causally associated with risk of mortality that is estimated 10 to 30 times higher for CKD patients undergoing dialysis th ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Novel Optical Microprobes for Ultra-Precise Intraocular Laser Surgery

    SBC: PhotonTech, LLC            Topic: NEI

    DESCRIPTION (provided by applicant): This STTR project proposes to develop a novel optical scalpel for ultra-precise ophthalmic laser surgery. Segmentation and removal of epiretinal membranes during vitreoretinal surgery is currently performed mechanically with both blunt and sharp dissection, which causes collateral damage to healthy retinal tissue. Conventional fiber-based surgical laser micropr ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  5. The effect of TLR4 inhibition on lung transplant ischemia-reperfusion injury

    SBC: X-IN8 BIOLOGICALS CORPORATION            Topic: NHLBI

    DESCRIPTION (provided by applicant): Ischemia-reperfusion injury (IRI) occurs in organs when circulation is interrupted, causing ischemia, and then ischemic tissue is reperfused. This leads to a series of biologic consequences, resulting in edema and inflammation. IRI is a significant problem in organ transplantation, because IRI is the major cause of primary graft failure and organ dysfunction af ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically modifying clot degradation (fibrinolysis), through inhibition of plasmin activity (PLact). However, the only FDA approved and most commonly used inhibitor of PLact in cardiovascular surgery, while eff ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Comprehensive MR Imaging of Elderly Vascular Function: Phase II

    SBC: MRI CARDIAC SERVICES, INC.            Topic: NIA

    DESCRIPTION (provided by applicant): The current proposal responds to program announcement PA-09-081, which has extended and replaced our Phase I announcement PAS-06-131 Applications of Imaging and Sensor Technologies for Clinical Aging Research. The purpose of the announcement is to improve imaging methods for measuring age-related changes in regulation of complex physiologic systems, including ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  8. Hip-Joint Resurfacing with Functional Human Cartilage

    SBC: Cytex Therapeutics, Inc.            Topic: NIAMS

    DESCRIPTION (provided by applicant): Degenerative joint disease accounts for substantial human suffering at tremendous social and economic cost. While prosthetic joint replacement is a well-established procedure, a finite life span makes this treatment unacceptable for younger or active individuals who often require progressively complicated revision surgeries. The goal of this Phase II STTR is to ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  9. New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto

    SBC: Nirvana Sciences, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government